Postponed to 2021, Global BSG, Zurich, 2nd Annual Pharma AI Summit (Speaker)

Oct 2020, Virtual, AI Application in BioPharma Summit (Summit Advisor, Session Chair)

Oct 2020, Bio-IT World, Virtual, Bio-IT World Expo & Conference (Session Chair)

June 2020, Global Genes, Virtual, RARE Drug Development Symposium (Speaker)

June 2020, BIO-Digital, Virtual, Can AI prevent Pandemics? (Moderator)

Mar 2020, Mol-Tri-Med, San Francisco.AI and Rare Diseases Treatment (Session Chair and Panel Moderator)

Mar 2020, Mol Tri-Med, San Francisco. Partnering for AI Startups and Pharma (Moderator)

Jan 2020, West Coast Australian American Leadership Dialogue, San Francisco and Los Angeles. Data analytics, healthcare, challenges, use cases, and business models (Panelist/Dialogue Delegate)

Nov 2019, Washington DC, USA: AI Enabled IND and NDA Workshop – Drug Development Series v1.0. (Producer/Host)

June 2019, Washington DC, USA: AI World Government. AI and Healthcare.
a) AAIH Primer in Healthcare,
b) How industry is using AI in Healthcare,
c) How Federal Agencies are Advancing Public Private Partnerships. (Producer/ Host)

May 2019, Shanghai, China: Asia Pharma R&D Leaders’ Summit 2019, AI Innovation in Pharma: “Strengthening Global Collaboration and Partnership for AI in Healthcare”. (Keynote)

Apr 2019, Toronto, Canada: Health Innovation Week Invest. "AI and Big Data - Therapeutics Investing". (Panelist)

Nov 2018, Seoul, Korea: Tv Chosun 6th Global Leaders Forum 2018, “The invisible is Changing the world: The Bio Revolution, the dream of immortality”. (Keynote)

Mar 2016, Nice, France: SEMI ISS Europe Reaching into a New Era: “Transforming Markets, New Applications, New opportunities for Nanoelectronics for Healthcare” (Keynote)

June 2014, Brussels, Belgium: IMEC Technology Forum 2014: “Generic silicon nanotechnologies for truly personalized healthcare” (Keynote)

April 2014, Turin, Italy: Bio-Europe Partnering: “Partnering with provider institutions: The new healthcare model?” (Interviewee/ Panelist)